WallStreetZenWallStreetZen

NYSE: CL
Colgate Palmolive Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CL

Based on 9 analysts offering 12 month price targets for Colgate Palmolive Co

Min Forecast
$80.00+3.05%
Avg Forecast
$89.56+15.36%
Max Forecast
$105.00+35.26%

Should I buy or sell CL stock?

Based on 9 analysts offering ratings for Colgate Palmolive Co.

Buy
Strong Buy
6 analysts 66.67%
Buy
0 analysts 0%
Hold
2 analysts 22.22%
Sell
0 analysts 0%
Strong Sell
1 analysts 11.11%
Although CL's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates CL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their CL stock forecasts and price targets.

CL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-10
lockedlocked$00.00+00.00%2025-10-08
lockedlocked$00.00+00.00%2025-10-08
lockedlocked$00.00+00.00%2025-10-03
lockedlocked$00.00+00.00%2025-10-02
Barclays
Bottom 5%
5
HoldMaintains$82.00+5.63%2025-10-01
Wells Fargo
Top 28%
73
Strong SellMaintains$80.00+3.05%2025-09-25
Citigroup
Bottom 12%
12
Strong BuyMaintains$105.00+35.26%2025-08-04
Morgan Stanley
Top 7%
94
Strong BuyMaintains$96.00+23.66%2025-08-04

1 of 1

Forecast return on equity

Is CL forecast to generate an efficient return?

Company
491.37%
Industry
155.68%
Market
-63.07%
CL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CL forecast to generate an efficient return on assets?

Company
19.74%
Industry
13.89%
CL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CL earnings per share forecast

What is CL's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$3.67+2.51%
Avg 2 year Forecast
$3.91+9.13%
Avg 3 year Forecast
$4.13+15.29%
CL's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CL revenue forecast

What is CL's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$20.3B+1.57%
Avg 2 year Forecast
$21.1B+5.7%
Avg 3 year Forecast
$21.9B+9.54%
CL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CL earnings growth forecast

How is CL forecast to perform vs Household & Personal Products companies and vs the US market?

Company
4.9%
Industry
7.49%
Market
15.54%
CL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CL revenue growth forecast

How is CL forecast to perform vs Household & Personal Products companies and vs the US market?

Company
3.11%
Industry
2.71%
Market
11.62%
CL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CL vs Household & Personal Product Stocks

TickerPricePrice TargetUp/downsideConsensus
CL$77.63$89.56+15.36%Buy
KMB$119.92$138.22+15.26%Buy
EL$95.27$96.33+1.12%Buy
KVUE$16.26$20.00+23.00%Buy
CHD$86.38$100.27+16.08%Hold
View Top Household & Personal Product Stocks

Colgate Palmolive Co Stock Forecast FAQ

Is Colgate Palmolive Co Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: CL) stock is to Buy CL stock.

Out of 9 analysts, 6 (66.67%) are recommending CL as a Strong Buy, 0 (0%) are recommending CL as a Buy, 2 (22.22%) are recommending CL as a Hold, 0 (0%) are recommending CL as a Sell, and 1 (11.11%) are recommending CL as a Strong Sell.

If you're new to stock investing, here's how to buy Colgate Palmolive Co stock.

What is CL's earnings growth forecast for 2025-2027?

(NYSE: CL) Colgate Palmolive Co's forecast annual earnings growth rate of 4.9% is not forecast to beat the US Household & Personal Products industry's average forecast earnings growth rate of 7.49%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.54%.

Colgate Palmolive Co's earnings in 2025 is $2,909,000,000.On average, 9 Wall Street analysts forecast CL's earnings for 2025 to be $2,966,008,747, with the lowest CL earnings forecast at $2,925,759,350, and the highest CL earnings forecast at $2,990,417,016. On average, 9 Wall Street analysts forecast CL's earnings for 2026 to be $3,157,557,080, with the lowest CL earnings forecast at $3,095,485,721, and the highest CL earnings forecast at $3,208,636,636.

In 2027, CL is forecast to generate $3,335,850,592 in earnings, with the lowest earnings forecast at $3,264,888,804 and the highest earnings forecast at $3,378,363,007.

What is CL's revenue growth forecast for 2025-2027?

(NYSE: CL) Colgate Palmolive Co's forecast annual revenue growth rate of 3.11% is forecast to beat the US Household & Personal Products industry's average forecast revenue growth rate of 2.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.62%.

Colgate Palmolive Co's revenue in 2025 is $19,999,000,000.On average, 7 Wall Street analysts forecast CL's revenue for 2025 to be $16,417,395,072,641, with the lowest CL revenue forecast at $16,217,362,845,591, and the highest CL revenue forecast at $16,526,175,936,794. On average, 7 Wall Street analysts forecast CL's revenue for 2026 to be $17,084,911,917,737, with the lowest CL revenue forecast at $16,744,322,816,971, and the highest CL revenue forecast at $17,222,952,800,055.

In 2027, CL is forecast to generate $17,704,844,762,349 in revenue, with the lowest revenue forecast at $17,499,637,497,421 and the highest revenue forecast at $17,817,022,578,588.

What is CL's forecast return on assets (ROA) for 2025-2028?

(NYSE: CL) forecast ROA is 19.74%, which is higher than the forecast US Household & Personal Products industry average of 13.89%.

What is CL's Price Target?

According to 9 Wall Street analysts that have issued a 1 year CL price target, the average CL price target is $89.56, with the highest CL stock price forecast at $105.00 and the lowest CL stock price forecast at $80.00.

On average, Wall Street analysts predict that Colgate Palmolive Co's share price could reach $89.56 by Oct 10, 2026. The average Colgate Palmolive Co stock price prediction forecasts a potential upside of 15.36% from the current CL share price of $77.63.

What is CL's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: CL) Colgate Palmolive Co's current Earnings Per Share (EPS) is $3.58. On average, analysts forecast that CL's EPS will be $3.67 for 2025, with the lowest EPS forecast at $3.62, and the highest EPS forecast at $3.70. On average, analysts forecast that CL's EPS will be $3.91 for 2026, with the lowest EPS forecast at $3.83, and the highest EPS forecast at $3.97. In 2027, CL's EPS is forecast to hit $4.13 (min: $4.04, max: $4.18).

What is CL's forecast return on equity (ROE) for 2025-2028?

(NYSE: CL) forecast ROE is 491.37%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.